Literature DB >> 17127233

Chemotherapeutic management of small bowel adenocarcinoma associated with Crohn's disease.

H W Bruckner1, V R Hrehorovich, H S Sawhney, S I Meeus, A M Coopeman.   

Abstract

Four patients with metastatic primary small bowel adenocarcinoma associated with Crohn's disease were successfully treated with low dose combination chemotherapy consisting of 5-fluorouracil, leucovorin and irinotecan with or without gemcitabine. Benefits included prolonged survival, objective responses, response of resistant tumors, downstaging, and a successful secondary complete resection (Ro) with a durable remission.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17127233     DOI： 10.1179/joc.2006.18.5.545

Source DB:  PubMed          Journal:  J Chemother        ISSN： 1120-009X            Impact factor:   1.714


  3 in total

1.  Successful treatment of duodenal adenocarcinoma with multiple liver metastases by S-1 + irinotecan (CPT-11).

Authors:  Tomoaki Yamasaki; Hiroko Nebiki; Eiji Sasaki; Osamu Kurai
Journal:  Clin J Gastroenterol       Date:  2009-07-01

2.  A case of small bowel adenocarcinoma in a patient with Crohn's disease detected by PET/CT and double-balloon enteroscopy.

Authors:  Chise Kodaira; Satoshi Osawa; Chihiro Mochizuki; Yoshihiko Sato; Masafumi Nishino; Takanori Yamada; Yasuhiro Takayanagi; Kosuke Takagaki; Ken Sugimoto; Shigeru Kanaoka; Takahisa Furuta; Mutsuhiro Ikuma
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

3.  Ileal Adenocarcinoma with Liver Metastasis in Patient with Crohn's Disease: A 9-Year Survival.

Authors:  Jiten P Kothadia; Deepa H Nagaraju; Seymour Katz; Howard Bruckner; Steven H Itzkowitz; Myron Schwartz
Journal:  Case Rep Oncol Med       Date:  2019-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.